7 results
2021 ACR/VF Guidelines for Management of Polyarteritis Nodosa (PAN)

#PAN #Polyarteritis #Nodosa #ACR2021 #Management #rheumatology #algorithm #vasculitis
Polyarteritis Nodosa ... (PAN) #PAN #Polyarteritis ... #Nodosa #ACR2021 ... #Management #rheumatology ... #algorithm #vasculitis
Vasculitis Management - ACR/VF 2021 Guidelines for Treatment & Management
 • Giant Cell Arteritis (GCA)
 •
Polyarteritis Nodosa ... Polyangiitis (MPA) • Eosinophilic ... #Treatment #ACR2021 ... #Guidelines #algorithm ... #rheumatology
2021 ACR/VF Guidelines for Management of Eosinophilic Granulomatosis with Polyangiitis (EGPA)

#EGPA #Eosinophilic #Granulomatosis #Polyangiitis #ACR2021 #Management
Guidelines for Management ... of Eosinophilic ... #Polyangiitis #ACR2021 ... #Management #rheumatology ... #algorithm #vasculitis
Polyarteritis Nodosa (PAN) - Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Severe Disease → Remission
Polyarteritis Nodosa ... (PAN) - Vasculitis ... Management Algorithm ... #Treatment #ACR2021 ... #rheumatology
Eosinophilic Granulomatosis with Polyangiitis (EGPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Active
Eosinophilic Granulomatosis ... Algorithm - ACR ... of Preference (Can ... #Treatment #ACR2021 ... #rheumatology
Giant Cell Arteritis (GCA) - Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Visual Symptoms/Loss or
) - Vasculitis Management ... Algorithm - ACR ... #Treatment #ACR2021 ... #Guidelines #algorithm ... #rheumatology
IgG4-Related Disease
Clinical history:  Man, 60 years, multiorgan involvement, unique or multiple inflammatory pseudotumor
4 phenotypes:
 •
Clinical history: Man ... glands, lymph nodes ... phase reactants, eosinophilia ... Disease #diagnosis #management ... workup #treatment #rheumatology